Literature DB >> 10674190

Cytochrome P450-mediated drug interactions.

D A Flockhart1, J R Oesterheld.   

Abstract

In this article, the authors have provided child psychiatrists with cytochromal concepts, illustrations of common CYP-based drug interactions, and CYP tables. Clinicians can use these tables to anticipate drug interactions. If two medications are listed on the same CYP, a drug interaction may occur, and depending on whether they are substrates, inducers, or inhibitors, clearance of one or both drugs may be altered. Because new information about CYPs rapidly becomes available, however, CYP tables have a short shelf life. To further predict and reduce the consequences of CYP-based drug interactions, child psychiatrists can limit their own formularies and review PubMed, Ovid, or other literature tracking programs each time they use two or more drugs (including nonpsychiatric ones). The following Internet websites can provide current CYP data: CYP charts http//:@www.dml.georgetown.edu/depts/ph armac ology/clinlist.html http//:@www.accp.com/p450.html CYP drug interaction program http//:@www.mhc.com/Cytochromes/ AIDS drug interactions http//:@www.tthhivclinic.com/interactions.htm http//:@www.fda.gov/oashi/aids/pitabv. htm l http//:@HIV.medscape.com/Medscape/HIV/DrugInteract+ ++ ion s/index.html http//:@www.hopkins-aids.edu/geneva/hilites_f le x_d rug.html.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674190

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  17 in total

Review 1.  [Cytochrom-P450 mediated drug interactions caused by antibiotics].

Authors:  Christiane Thallinger; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2006-09

Review 2.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Authors:  V Ozdemir; N H Shear; W Kalow
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  A simultaneous assessment of CYP3A4 metabolism and induction in the DPX-2 cell line.

Authors:  Olga Trubetskoy; Bryan Marks; Thomas Zielinski; Mei-Fei Yueh; Judy Raucy
Journal:  AAPS J       Date:  2005-03-04       Impact factor: 4.009

5.  Effects of zedoary turmeric oil on P450 activities in rats with liver cirrhosis induced by thioacetamide.

Authors:  Jing-Jing Cheng; Nai-Bin Yang; Liang Wu; Jia-Le Lin; Ge-Xin Dai; Jia-Yin Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  The Impact of CYP1A2 and CYP2E1 Genes Polymorphism on Theophylline Response.

Authors:  Em Sutrisna
Journal:  J Clin Diagn Res       Date:  2016-11-01

7.  Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors:  Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal:  Eur J Clin Pharmacol       Date:  2010-01-19       Impact factor: 2.953

Review 8.  Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.

Authors:  Sarah C Preissner; Michael F Hoffmann; Robert Preissner; Mathias Dunkel; Andreas Gewiess; Saskia Preissner
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

Review 9.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions.

Authors:  Saskia Preissner; Katharina Kroll; Mathias Dunkel; Christian Senger; Gady Goldsobel; Daniel Kuzman; Stefan Guenther; Rainer Winnenburg; Michael Schroeder; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2009-11-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.